Met-Enkephalin – 10MG per vial

Clinical Test Expectation – Met-Enkephalin – Human Subjects : Inhibit tumor growth and metastasis. Essential role in cell proliferation and tissue organization during development. Immunoregulatory activity with cancer. Help reduce the sensation of pain (nociception) and increase relief from pain (analgesia)
Strength – 10MG per vial

Introduction
Met-enkephalin (MENK) is an endogenous neuropeptide, which has the ability to inhibit tumor growth and metastasis. This peptides acts as a neurotransmitters and neuromodulators throughout the nervous system and various end-organ targets. Additionally, research has found that met-enkephalin has an essential role in cell proliferation and tissue organization during development.Met-Enkephalin, also called opioid growth factor (OGF), is a naturally occurring endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin with Leu-enkephalin. Enkephalins are considered the primary endogenous ligands of the delta-opioid receptor, due to their high potency and selectivity for the site over other endogenous opioids. The Met-Enkephalin peptide competes with and mimics the effects of opiate drug

Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF), is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.

Methionine enkephalin (MENK), an endogenous neuropeptide has a crucial role in both neuroendocrine and immune systems. MENK is believed to have an immunoregulatory activity to have cancer biotherapy activity by binding to the opioid receptors on immune and cancer cells. Enkephalins are mainly involved in decreasing pain, reducing inflammation, preventing cancer cell growth, and increasing immune cell activity, and play a role in several diseases. When released, enkephalins help reduce the sensation of pain (nociception) and increase relief from pain (analgesia). They achieve these responses by binding to opioid receptors in the spinal cord and certain regions of the brain and activating their respective pathways

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/